导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 55.06% | 43/1050 |
| 近一周 | 1.74% | 124/1104 |
| 近一月 | 1.28% | 57/1103 |
| 近一季 | -15.94% | 881/1092 |
| 近半年 | 41.94% | 38/1070 |
| 近一年 | 67.94% | 36/1018 |
| 近两年 | 133.98% | 130/926 |
| 近三年 | 87.51% | 117/834 |
| 成立以来 | 10.50% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
5.90% 114/1070 |
91.92% 67/1101 |
- - |
- - |
| 2025 | 45.49% 240/1065 |
-2.29% 925/1014 |
-2.05% 847/1038 |
40.51% 183/1050 |
8.19% 70/1065 |
| 2024 | -14.96% 856/1011 |
-0.97% 365/960 |
-3.32% 534/983 |
1.02% 950/991 |
-12.08% 958/1011 |
| 2023 | -10.56% 350/952 |
1.96% 514/880 |
-3.10% 382/895 |
-7.05% 433/915 |
-2.61% 285/952 |
| 2022 | -30.69% 646/867 |
-16.44% 325/773 |
3.07% 626/806 |
-10.51% 280/845 |
-10.08% 787/867 |
| 2021 | 1.30% 341/740 |
-7.56% 437/580 |
13.64% 269/659 |
-2.55% 274/704 |
-1.04% 483/740 |
| 2020 | 61.01% 189/554 |
-1.72% 207/419 |
29.16% 136/466 |
9.30% 268/517 |
16.05% 184/554 |
| 2019 | 47.28% 172/410 |
30.62% 343/1146 |
0.55% 278/1228 |
6.34% 175/390 |
5.45% 334/410 |
| 2018 | -34.36% 264/349 |
- - |
-11.81% 588/990 |
-9.76% 750/1000 |
-14.68% 864/1080 |
| 2017 | 1.45% 173/285 |
- - |
- - |
- - |
- - |
| 2016 | -8.09% 61/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 嘉实事件驱动股票 VS. 东吴新产业精选股票A(580008) |